doxycycline hyclate 200 MG Delayed Release Oral Tablet

RxCUI
1423080
RxNorm name
doxycycline hyclate 200 MG Delayed Release Oral Tablet
Display name
Doxycycline (Oral Pill)
Full name
doxycycline hyclate 200 MG Delayed Release Oral Tablet
Term type
SCD
Status
Active
Strength
200 mg
Dose form
DR Tab
Route
Oral Pill
Updated
2026-11-12 18:36:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062013
Active start
062013
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
doxycycline hyclate200 MG / 1 EACHdoxycyclinedoxycycline

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Delayed Release Oral Tablet10312

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
doxycycline3640

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0591-4575-600591-4575Doxycycline Hyclate Doxycycline HyclateActavis Pharma, Inc.ANDA090134
23155-611-0423155-611DOXYCYCLINE HYCLATE doxycycline hyclateHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.ANDA200856
23155-611-0623155-611DOXYCYCLINE HYCLATE doxycycline hyclateHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.ANDA200856
43547-325-0643547-325DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATESolco Healthcare US LLCANDA207494
43547-325-1043547-325DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATESolco Healthcare US LLCANDA207494
43547-325-5043547-325DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATESolco Healthcare US LLCANDA207494
46708-484-3046708-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals LimitedANDA213075
46708-484-3146708-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals LimitedANDA213075
46708-484-6046708-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals LimitedANDA213075
46708-484-7146708-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals LimitedANDA213075
62332-484-3062332-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals Inc.ANDA213075
62332-484-3162332-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals Inc.ANDA213075
62332-484-6062332-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals Inc.ANDA213075
62332-484-7162332-484Doxycycline Hyclate Doxycycline HyclateAlembic Pharmaceuticals Inc.ANDA213075
68308-716-3068308-716Doxycycline Hyclate Doxycycline HyclateMayne Pharma Commercial LLCNDA050795
68308-716-6068308-716Doxycycline Hyclate Doxycycline HyclateMayne Pharma Commercial LLCNDA050795

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA0901340591-4575Doxycycline Hyclate Doxycycline HyclateANDAActavis Pharma, Inc.
ANDA20085623155-611DOXYCYCLINE HYCLATE doxycycline hyclateANDAHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
ANDA20749443547-325DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATEANDASolco Healthcare US LLC
ANDA21307546708-484Doxycycline Hyclate Doxycycline HyclateANDAAlembic Pharmaceuticals Limited
NDA05079568308-716Doxycycline Hyclate Doxycycline HyclateNDA AUTHORIZED GENERICMayne Pharma Commercial LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 21 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00378453391rxnav_ndcsyes
00591457560rxnav_ndcsyes
23155061104rxnav_ndcsyes
23155061106rxnav_ndcsyes
43547032506rxnav_ndcsyes
43547032510rxnav_ndcsyes
43547032550rxnav_ndcsyes
46708048430rxnav_ndcsyes
46708048431rxnav_ndcsyes
46708048460rxnav_ndcsyes
46708048471rxnav_ndcsyes
62332048430rxnav_ndcsyes
62332048431rxnav_ndcsyes
62332048460rxnav_ndcsyes
62332048471rxnav_ndcsyes
68308071630rxnav_ndcsyes
68308071660rxnav_ndcsyes
00378453305rxnav_historical
00378453377rxnav_historical
00378453393rxnav_historical
69499032515rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Doxycycline HyclateDOXYCYCLINE HYCLATEAlembic Pharmaceuticals Inc.3ae4ca12-be39-46b9-bc4c-f8356776c1752026-04-28Warnings, Adverse reactionsExact identifier
ndc (package): 62332-484-71
ndc (package): 62332-484-60
ndc (package): 62332-484-30
ndc (package): 62332-484-31
ndc (product): 62332-484
ndc11 (package): 62332048471
ndc11 (package): 62332048460
ndc11 (package): 62332048431
ndc11 (package): 62332048430
rxcui: 1423080
DOXYCYCLINE HYCLATE DELAYED RELEASEDOXYCYCLINE HYCLATEHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.f5ee43b2-d6ca-4819-a3d7-07f8421015d72025-12-16Warnings, Adverse reactionsExact identifier
ndc (package): 23155-611-04
ndc (package): 23155-611-06
ndc (product): 23155-611
ndc11 (package): 23155061104
ndc11 (package): 23155061106
rxcui: 1423080
DOXYCYCLINE HYCLATEDOXYCYCLINE HYCLATESolco Healthcare US LLC0a18d4c7-9484-4d3e-b61b-e81fe63fefec2025-10-31Warnings, Adverse reactionsExact identifier
ndc (package): 43547-325-10
ndc (package): 43547-325-06
ndc (package): 43547-325-50
ndc (product): 43547-325
ndc11 (package): 43547032510
ndc11 (package): 43547032550
ndc11 (package): 43547032506
rxcui: 1423080
Doxycycline HyclateDOXYCYCLINE HYCLATEMayne Pharma Commercial LLCcd2ab9b8-9619-4199-8a5d-83377b3274d12025-04-14Warnings, Adverse reactionsExact identifier
ndc (package): 68308-716-30
ndc (package): 68308-716-60
ndc (product): 68308-716
ndc11 (package): 68308071660
ndc11 (package): 68308071630
rxcui: 1423080
Doxycycline HyclateDOXYCYCLINE HYCLATEActavis Pharma, Inc.c2b08332-3256-4658-965a-ede3d973a3882025-04-01Warnings, Adverse reactionsExact identifier
ndc (package): 0591-4575-60
ndc (product): 0591-4575
ndc11 (package): 00591457560
rxcui: 1423080
Doxycycline HyclateDOXYCYCLINE HYCLATEAlembic Pharmaceuticals Limited44ac5de1-c0c6-4d58-9a49-b2dae60ea9212023-04-10Warnings, Adverse reactionsExact identifier
ndc (package): 46708-484-31
ndc (package): 46708-484-30
ndc (package): 46708-484-60
ndc (package): 46708-484-71
ndc (product): 46708-484
ndc11 (package): 46708048430
ndc11 (package): 46708048431
ndc11 (package): 46708048460
ndc11 (package): 46708048471
rxcui: 1423080

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f5ee43b2-d6ca-4819-a3d7-07f8421015d7doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]234These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 196720251216
cd2ab9b8-9619-4199-8a5d-83377b3274d1doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]215These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 196720250414
3ae4ca12-be39-46b9-bc4c-f8356776c175doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]29These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 196720260428
c2b08332-3256-4658-965a-ede3d973a388doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]28These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 196720250401
0a18d4c7-9484-4d3e-b61b-e81fe63fefecdoxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]27These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 196720251031
44ac5de1-c0c6-4d58-9a49-b2dae60ea921doxycycline hyclate 200 MG Delayed Release Oral Tablet [PSN] · doxycycline hyclate 200 MG Delayed Release Oral Tablet [SCD]22These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 196720230410

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
3ae4ca12-be39-46b9-bc4c-f8356776c175These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited20260428
f5ee43b2-d6ca-4819-a3d7-07f8421015d7These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited20251216
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20251031
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20251031
f5ee43b2-d6ca-4819-a3d7-07f8421015d7These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | USV Private Limited20251017
cd2ab9b8-9619-4199-8a5d-83377b3274d1These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Mayne Pharma Commercial LLC | Mayne Pharma International Pty Ltd | Catalent Greenville, Inc.20250414
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
c2b08332-3256-4658-965a-ede3d973a388These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Actavis Pharma, Inc.20250401
f5ee43b2-d6ca-4819-a3d7-07f8421015d7These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | AVET LIFESCIENCES PRIVATE LIMITED | USV Private Limited20231031
44ac5de1-c0c6-4d58-9a49-b2dae60ea921These highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See Full Prescribing Information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use Initial U.S. Approval: 1967Alembic Pharmaceuticals Limited20230410
0a18d4c7-9484-4d3e-b61b-e81fe63fefecThese highlights do not include all the information needed to use DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS. DOXYCYCLINE HYCLATE delayed-release tablets, for oral use. Initial U.S. Approval: 1967Solco Healthcare US LLC | Prinston Pharmaceutical, Inc. | Zhejiang Huahai Pharmaceutical Co., Ltd.20220922

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4doxycycline
ATCJ01AATetracyclinesATC1-4doxycycline
FDASPLD013754TetracyclinesCHEMhas_chemical_structuredoxycycline
FDASPLN0000175882Tetracycline-class DrugEPChas_epcdoxycycline
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline hyclate
MEDRTD004318DoxycyclineCHEMhas_ingredientdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline
MEDRTD013752TetracyclineCHEMci_chemclassdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline hyclate
MEDRTD000881AnthraxDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline
MEDRTD002169Campylobacter InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline hyclate
MEDRTD002675Child, PreschoolDISEASEci_withdoxycycline
MEDRTD002771CholeraDISEASEmay_treatdoxycycline hyclate
MEDRTD002771CholeraDISEASEmay_treatdoxycycline
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline hyclate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline
MEDRTD006100Granuloma InguinaleDISEASEmay_treatdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline hyclate
MEDRTD008107Liver DiseasesDISEASEci_withdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline
MEDRTD008288MalariaDISEASEmay_preventdoxycycline hyclate
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline
MEDRTD009175Mycoplasma InfectionsDISEASEmay_treatdoxycycline hyclate
MEDRTD010930PlagueDISEASEmay_treatdoxycycline
MEDRTD010930PlagueDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline hyclate
MEDRTD010996Pleural EffusionDISEASEmay_treatdoxycycline
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline hyclate
MEDRTD018410Pneumonia, BacterialDISEASEmay_treatdoxycycline
MEDRTD011247PregnancyDISEASEci_withdoxycycline hyclate
MEDRTD011247PregnancyDISEASEci_withdoxycycline
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline hyclate
MEDRTD009956PsittacosisDISEASEmay_treatdoxycycline
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012061Relapsing FeverDISEASEmay_treatdoxycycline
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline hyclate
MEDRTD012373Rocky Mountain Spotted FeverDISEASEmay_treatdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline
MEDRTD012598SclerosisDISEASEinducesdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline hyclate
MEDRTD013587SyphilisDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline
MEDRTD014141TrachomaDISEASEmay_treatdoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline hyclate
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadoxycycline
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline hyclate
MEDRTN0000008334Cell Membrane AlterationPEhas_pedoxycycline
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline hyclate
MEDRTN0000008732Decreased MitosisPEhas_pedoxycycline
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline hyclate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pedoxycycline

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH200 MG (expressed as doxycycline hyclate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA090134
CODESANDAANDA200856
CODESANDAANDA207494
CODESANDAANDA213075
CODESVUID4032509
NAMESPrescribable Synonymdoxycycline hyclate 200 MG Delayed Release Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File